Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Avenue Therapeutics Inc market cap is $922,591.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Avenue Therapeutics Inc 52 week high is $0.957 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Avenue Therapeutics Inc 52 week low is $0.15 as of November 17, 2026.
Avenue Therapeutics Inc stock price today is $0.28.
Avenue Therapeutics Inc stock price yesterday was $0.3053.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Avenue Therapeutics Inc's P/E ratio is -0.33.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Avenue Therapeutics Inc P/B ratio is -12.3023.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Avenue Therapeutics Inc 50-day moving average is $0.4376.